Resultados de la búsqueda 301-310 of 2391 for High-Intensity Interval Training

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    It also aims to determine the rate and duration of grade 3 or higher ... This phase II trial compares the impact of subcutaneous (SC) nivolumab given ...

  2. Intervalo QT largo - Mayo Clinic

    Es un cambio en la forma en que las cavidades inferiores del corazón envían señales. En un intervalo QT largo, el corazón tarda más de lo normal en recargarse ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... high-risk bladder cancer. Maintenance therapy, such as paclitaxel albumin ... high-grade serous ovarian cancer (HGSOC), including cancers of ovarian ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla. The purpose of this study is to evaluate the utility, safety, effectiveness, and cost of physical therapy on elective spine surgery patients.

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... high and very high risk relapsed FHWT (those treated with 3 or more drugs for the initial WT). A Study to Evaluate Outpatient Blinatumomab in Subjects ...

  7. Radiología - Ensayos clínicos - Mayo Clinic

    ... impact on treatment and errors will be caught and corrected by the QC process. Because the algorithm will not be used solely for diagnosis or inform ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to characterize the risk of scoliosis progression based on local three-dimensional vertebral and pelvic measurements present on ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Using radiation techniques, such as intensity modulated radiotherapy to ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...